© 2021 MJH Life Sciences and Gene Therapy Live. All rights reserved.
© 2021 MJH Life Sciences™ and Gene Therapy Live. All rights reserved.
Detailed data from the phase 3 trial, including safety findings, which were in line with previous studies, will be presented at a future scientific meeting.
Details enhance knowledge of biological pathways that contribute to disease pathogenesis.
The chief medical officer of Eyevensys discussed the company’s work in developing sustained drug delivery systems.